Caplin Point Laboratories Limited (BOM: 524742)

Caplin Point Laboratories Statistics

Total Valuation

Caplin Point Laboratories has a market cap or net worth of INR 175.67 billion. The enterprise value is 168.49 billion.

Market Cap	175.67B
Enterprise Value	168.49B

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	Sep 23, 2024

Share Statistics

Caplin Point Laboratories has 76.01 million shares outstanding. The number of shares has decreased by -0.10% in one year.

Current Share Class	n/a
Shares Outstanding	76.01M
Shares Change (YoY)	-0.10%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	68.90%
Owned by Institutions (%)	4.31%
Float	19.31M

Valuation Ratios

The trailing PE ratio is 35.75 and the forward PE ratio is 32.06.

PE Ratio	35.75
Forward PE	32.06
PS Ratio	9.58
PB Ratio	7.11
P/TBV Ratio	7.15
P/FCF Ratio	76.05
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.87, with an EV/FCF ratio of 72.94.

EV / Earnings	34.14
EV / Sales	9.19
EV / EBITDA	27.87
EV / EBIT	30.97
EV / FCF	72.94

Financial Position

The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.00.

Current Ratio	6.07
Quick Ratio	4.53
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.01
Interest Coverage	937.91

Financial Efficiency

Return on equity (ROE) is 21.24% and return on invested capital (ROIC) is 14.52%.

Return on Equity (ROE)	21.24%
Return on Assets (ROA)	12.74%
Return on Capital (ROIC)	14.52%
Revenue Per Employee	5.38M
Profits Per Employee	1.45M
Employee Count	3,406
Asset Turnover	0.69
Inventory Turnover	2.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+84.39%
50-Day Moving Average	2,089.24
200-Day Moving Average	1,664.28
Relative Strength Index (RSI)	55.16
Average Volume (20 Days)	12,642

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Caplin Point Laboratories had revenue of INR 18.33 billion and earned 4.94 billion in profits. Earnings per share was 64.65.

Revenue	18.33B
Gross Profit	10.45B
Operating Income	5.44B
Pretax Income	6.14B
Net Income	4.94B
EBITDA	6.03B
EBIT	5.44B
Earnings Per Share (EPS)	64.65

Balance Sheet

The company has 8.27 billion in cash and 24.30 million in debt, giving a net cash position of 8.24 billion or 108.43 per share.

Cash & Cash Equivalents	8.27B
Total Debt	24.30M
Net Cash	8.24B
Net Cash Per Share	108.43
Equity (Book Value)	25.75B
Book Value Per Share	324.91
Working Capital	16.69B

Cash Flow

In the last 12 months, operating cash flow was 3.75 billion and capital expenditures -1.44 billion, giving a free cash flow of 2.31 billion.

Operating Cash Flow	3.75B
Capital Expenditures	-1.44B
Free Cash Flow	2.31B
FCF Per Share	30.39

Margins

Gross margin is 57.02%, with operating and profit margins of 29.68% and 26.93%.

Gross Margin	57.02%
Operating Margin	29.68%
Pretax Margin	33.52%
Profit Margin	26.93%
EBITDA Margin	32.92%
EBIT Margin	29.68%
FCF Margin	12.60%

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.22%.

Dividend Per Share	5.00
Dividend Yield	0.22%
Dividend Growth (YoY)	11.11%
Years of Dividend Growth	11
Payout Ratio	7.69%
Buyback Yield	0.10%
Shareholder Yield	0.32%
Earnings Yield	2.80%
FCF Yield	1.31%

Stock Splits

The last stock split was on October 19, 2016. It was a forward split with a ratio of 5.

Last Split Date	Oct 19, 2016
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a